Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Other Non-Current Liabilities (2018 - 2025)

Quantum Biopharma's Other Non-Current Liabilities history spans 8 years, with the latest figure at $7.8 million for Q2 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 776068300.0% to $7.8 million in Q2 2025 year-over-year; TTM through Jun 2025 was $7.8 million, a 776068300.0% increase, with the full-year FY2024 number at $212002.0, changed N/A from a year prior.
  • Other Non-Current Liabilities hit $7.8 million in Q2 2025 for Quantum Biopharma, up from $2.8 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for QNTM hit a ceiling of $7.8 million in Q2 2025 and a floor of $1.0 in Q2 2024.
  • Historically, Other Non-Current Liabilities has averaged $1.5 million across 5 years, with a median of $438082.0 in 2022.
  • Biggest five-year swings in Other Non-Current Liabilities: crashed 100.0% in 2024 and later soared 776068300.0% in 2025.
  • Tracing QNTM's Other Non-Current Liabilities over 5 years: stood at $5.1 million in 2021, then crashed by 95.26% to $243594.0 in 2022, then crashed by 46.48% to $130383.0 in 2023, then surged by 62.6% to $212002.0 in 2024, then surged by 3560.67% to $7.8 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for QNTM at $7.8 million in Q2 2025, $2.8 million in Q1 2025, and $212002.0 in Q4 2024.